P169 Long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis: pooled analysis of 4 clinical trials

PW Noble; C Albera; L Lancaster; P Hormel; H Hulter; U Costabel

doi:10.1136/thoraxjnl-2016-209333.312

Article info

Treating Idiopathic Pulmonary Fibrosis

P169 Long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis: pooled analysis of 4 clinical trials

Authors

PW Noble 1Cedars-Sinai Medical Centre, Los Angeles, USA PubMed articles Google scholar articles
C Albera 2University of Turin, Turin, Italy PubMed articles Google scholar articles
L Lancaster 3Vanderbilt University Medical Centre, Nashville, USA PubMed articles Google scholar articles
P Hormel 4Genentech Inc., South San Francisco, USA PubMed articles Google scholar articles
H Hulter 4Genentech Inc., South San Francisco, USA PubMed articles Google scholar articles
U Costabel 5Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany PubMed articles Google scholar articles

Citation

Noble P, Albera C, Lancaster L, et al

P169 Long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis: pooled analysis of 4 clinical trials

Thorax 2016;71:A175-A176.

Publication history

First published November 15, 2016.

Online issue publication

September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password